- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.75 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x 8IE: (4R)-3-methyl-5-[(4R)-4-methyl-3,4-dihydroisoquinolin-2(1H)-yl]thieno[2,3-e][1,2,4]triazolo[4,3-c]pyrimidine(Non-covalent)
8IE.1: 15 residues within 4Å:- Chain A: Y.30, L.34, C.37, L.38, G.43, C.46, H.47, F.50, F.89, R.127, Y.360, L.363, V.364, G.367, M.368
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.34, A:L.38, A:H.47, A:F.89, A:V.364
- Hydrogen bonds: A:R.127
8IE.7: 13 residues within 4Å:- Chain A: S.22, F.27, L.29, Y.30, F.33, L.49, L.53
- Chain B: Y.23, Y.30, L.49, L.53, I.58
- Ligands: 8IE.8
7 PLIP interactions:6 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:L.29, A:F.33, A:F.33, A:F.33, A:L.49, A:L.53, B:L.49
8IE.8: 13 residues within 4Å:- Chain A: Y.30, L.49, L.53, I.58
- Chain B: S.22, F.27, L.29, Y.30, F.33, C.37, L.49, L.53
- Ligands: 8IE.7
6 PLIP interactions:1 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:L.49, B:L.29, B:F.33, B:F.33, B:L.49, B:L.53
8IE.9: 13 residues within 4Å:- Chain B: L.34, L.38, G.43, C.46, H.47, F.50, F.89, R.127, Y.360, L.363, V.364, G.367, M.368
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:L.34, B:L.38, B:H.47, B:F.89
- Hydrogen bonds: B:R.127
- 2 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
FMN.2: 24 residues within 4Å:- Chain A: A.86, A.87, G.88, K.91, G.110, T.111, I.125, I.134, N.136, C.138, N.204, K.261, S.289, N.290, T.291, S.309, G.310, L.313, S.337, G.338, G.339, Y.360, S.361
- Ligands: ORO.3
24 PLIP interactions:24 interactions with chain A- Hydrophobic interactions: A:I.125, A:I.134, A:N.136, A:Y.360
- Hydrogen bonds: A:A.87, A:K.91, A:T.111, A:T.111, A:T.111, A:N.204, A:K.261, A:K.261, A:N.290, A:S.309, A:G.310, A:S.337, A:G.338, A:G.339, A:Y.360, A:S.361
- Water bridges: A:S.173, A:S.337, A:C.362
- pi-Stacking: A:Y.360
FMN.10: 23 residues within 4Å:- Chain B: A.86, A.87, G.88, K.91, G.110, T.111, I.125, N.136, N.204, S.206, K.261, S.289, N.290, T.291, S.309, G.310, L.313, S.337, G.338, G.339, Y.360, S.361
- Ligands: ORO.11
26 PLIP interactions:26 interactions with chain B- Hydrophobic interactions: B:I.125, B:N.136, B:Y.360
- Hydrogen bonds: B:A.87, B:T.111, B:T.111, B:T.111, B:N.204, B:S.206, B:K.261, B:K.261, B:N.290, B:S.309, B:S.309, B:G.310, B:S.337, B:G.338, B:G.339, B:Y.360, B:S.361, B:S.361
- Water bridges: B:S.173, B:G.338, B:I.340, B:I.340
- pi-Stacking: B:Y.360
- 2 x ORO: OROTIC ACID(Non-covalent)
ORO.3: 12 residues within 4Å:- Chain A: K.91, N.136, S.137, C.138, G.139, F.140, N.204, S.207, N.209, N.290, T.291
- Ligands: FMN.2
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:F.140
- Hydrogen bonds: A:N.136, A:N.136, A:N.136, A:G.139, A:F.140, A:N.204, A:N.209, A:N.290, A:N.290, A:T.291
- Water bridges: A:T.111
- Salt bridges: A:K.91
ORO.11: 11 residues within 4Å:- Chain B: N.136, C.138, G.139, F.140, N.204, S.207, P.208, N.209, N.290, T.291
- Ligands: FMN.10
11 PLIP interactions:11 interactions with chain B- Hydrogen bonds: B:N.136, B:N.136, B:C.138, B:G.139, B:F.140, B:N.204, B:N.209, B:N.290, B:N.290, B:T.291
- Salt bridges: B:K.91
- 1 x ACT: ACETATE ION(Non-functional Binders)
ACT.4: 2 residues within 4Å:- Chain A: R.376, H.380
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:H.380
- 1 x P4K: polyethylene glycol(Non-covalent)
P4K.5: 9 residues within 4Å:- Chain A: R.156, Q.159, E.160, S.166, F.246, F.249, N.250, T.251, K.253
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.253
- 2 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 3 residues within 4Å:- Chain A: I.125, F.126, R.127
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:R.127, A:R.127
- Water bridges: A:R.127, A:R.127
- Salt bridges: A:R.127
SO4.12: 4 residues within 4Å:- Chain B: L.38, G.43, F.126, R.127
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:G.43, B:R.127, B:R.127
- Salt bridges: B:R.127
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Seattle Structural Genomics Center for Infectious Disease (SSGCID) et al., Crystal Structure of Dihydroorotate dehydrogenase from Plasmodium falciparum in complex with Orotate, FMN, and inhibitor NCGC00600348-01. To Be Published
- Release Date
- 2021-09-29
- Peptides
- Dihydroorotate dehydrogenase (quinone), mitochondrial: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.75 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x 8IE: (4R)-3-methyl-5-[(4R)-4-methyl-3,4-dihydroisoquinolin-2(1H)-yl]thieno[2,3-e][1,2,4]triazolo[4,3-c]pyrimidine(Non-covalent)
- 2 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
- 2 x ORO: OROTIC ACID(Non-covalent)
- 1 x ACT: ACETATE ION(Non-functional Binders)
- 1 x P4K: polyethylene glycol(Non-covalent)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Seattle Structural Genomics Center for Infectious Disease (SSGCID) et al., Crystal Structure of Dihydroorotate dehydrogenase from Plasmodium falciparum in complex with Orotate, FMN, and inhibitor NCGC00600348-01. To Be Published
- Release Date
- 2021-09-29
- Peptides
- Dihydroorotate dehydrogenase (quinone), mitochondrial: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B